Skip to main content

Ikarian Capital, LLC

Position in HROW — Harrow, Inc.

CIK 1778253 DALLAS, TX

Position in HROW

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$19,147,837
+$10,163,834 QoQ
Shares Held
543,047
+196.2% QoQ
Ownership
1.46%
of shares outstanding
% of Portfolio
2.71%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2020
7 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in HROW Over Time

Shares Held

Position Value (USD)

Derivatives in HROW

reported options exposure · as of Dec 31, 2025
CallValue
$24,975,300
CallShares
509,700
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

Ikarian Capital, LLC holds $37,161,250 across 6 Drug Manufacturers - Specialty & Generic names. HROW ranks #1 (51.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 HROW
Harrow, Inc.
This page
543,047 $19,147,837

All Filings in HROW

Export CSV
8 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $19,147,837 543,047
2025-12-31 $24,975,300 509,700
2025-12-31 $8,984,003 183,347
2025-09-30 $13,957,746 289,700
2025-03-31 $1,550,780 58,300
2024-12-31 $1,955,965 58,300
2020-12-31 $2,117,044 308,607
2020-09-30 $2,563,613 458,607